We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
Cap. Flow
+$324M
Cap. Flow %
2.32%
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391

Top Buys

Rank Stock Value
1
MUB icon
iShares National Muni Bond ETF
MUB
+$176M
2
INFY icon
Infosys
INFY
+$102M
3
K
Kellanova
K
+$74.6M
4
AMZN icon
Amazon
AMZN
+$58.6M
5
BABA icon
Alibaba
BABA
+$52.5M

Sector Composition

Rank Sector Weight
1 Technology 10.38%
2 Financials 4.13%
3 Consumer Discretionary 2.33%
4 Communication Services 2.26%
5 Healthcare 2.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IOVA icon
1151
Iovance Biotherapeutics
IOVA
$2.23B
$70.9K ﹤0.01%
41,211
EA icon
1152
Electronic Arts
EA
$52.4B
$70.4K ﹤0.01%
441
+438
+14,600% +$64.8K
LAZR
1153
DELISTED
Luminar Technologies
LAZR
$68.3K ﹤0.01%
23,786
CRMLW icon
1154
Critical Metals Corp Warrants
CRMLW
$13M
$67.7K ﹤0.01%
148,445
RLX icon
1155
RLX Technology
RLX
$2.48B
$64.9K ﹤0.01%
29,358
PCG icon
1156
CALL
PG&E
PCG
$47.8B
$64.1K ﹤0.01%
4,600
-5,300
-54% -$86.2K
PSFE.WS
1157
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$64K ﹤0.01%
3,877,444
ADBE icon
1158
Adobe
ADBE
$89.5B
$63.4K ﹤0.01%
+164
New +$63.2K
GGROW
1159
Gogoro Inc Warrant
GGROW
$62.9K ﹤0.01%
4,834,590
IKT icon
1160
Inhibikase Therapeutics
IKT
$366M
$60.6K ﹤0.01%
31,092
DMAAR
1161
Drugs Made In America Acquisition Corp Rights
DMAAR
$60.1K ﹤0.01%
500,000
PLMKW
1162
Plum Acquisition Corp IV Warrants
PLMKW
$3.88M
$60K ﹤0.01%
250,000
UHGWW
1163
DELISTED
United Homes Group Warrant
UHGWW
$59.5K ﹤0.01%
73,510
TYL icon
1164
Tyler Technologies
TYL
$12.2B
$59.3K ﹤0.01%
+100
New +$56.6K
CSX icon
1165
CSX Corp
CSX
$98.6B
$59.1K ﹤0.01%
1,812
-21,842
-92% -$657K
MDAIW icon
1166
Spectral AI Warrants
MDAIW
$5.79M
$58.3K ﹤0.01%
83,333
SEER icon
1167
Seer Inc
SEER
$108M
$55.7K ﹤0.01%
26,029
-3,879
-13% -$7.77K
HAL icon
1168
Halliburton
HAL
$27.9B
$54.6K ﹤0.01%
2,677
+513
+24% +$10.8K
REPL icon
1169
PUT
Replimune Group
REPL
$814M
$53.9K ﹤0.01%
+5,800
New +$50.6K
VLN.WS icon
1170
Valens Semiconductor Ltd Warrants
VLN.WS
$52.5K ﹤0.01%
1,017,306
+125,210
+14% +$6.29K
LZM.WS icon
1171
Lifezone Metals Ltd Warrants
LZM.WS
$51.9K ﹤0.01%
134,203
PRENW
1172
Prenetics Global Ltd Warrant
PRENW
$136K
$51K ﹤0.01%
1,303,861
EOSEW
1173
DELISTED
Eos Energy Enterprises Warrant
EOSEW
$50.8K ﹤0.01%
+108,138
New +$44.9K
STT icon
1174
State Street
STT
$50.9B
$50.4K ﹤0.01%
+474
New +$43.8K
SVIIR
1175
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$49K ﹤0.01%
350,000

Similar funds

LMR Partners's Q2 2025 Portfolio in Review

As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
  • LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
  • LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
  • LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
  • LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
  • LMR Partners opened 418 new positions and closed 391 in Q2 2025.
  • LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.